Bolt Biotherapeutics, Inc. (BOLT)
Nasdaq: BOLT · Pharmaceutical Preparations · Redwood City, CA · filing with the SEC since 2015
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Report filed | Mar 12, 2026 | Mar 24, 2025 | Mar 21, 2024 | Mar 29, 2023 | Mar 30, 2022 | Mar 31, 2021 |
| Revenue | 7,695 | 7,690 | 7,876 | 5,729 | 1,260 | 231 |
| Research and development | 28,533 | 57,469 | 61,542 | 73,123 | 75,655 | 40,357 |
| General and administrative | 13,795 | 18,457 | 22,530 | 22,927 | 18,393 | 9,056 |
| Total operating expenses | 43,808 | 80,738 | 84,072 | 96,050 | 94,048 | 49,413 |
| Operating income | -36,113 | -73,048 | -76,196 | -90,321 | -92,788 | -49,182 |
| Interest and investment income | 2,496 | 5,255 | 6,999 | 2,223 | 281 | 199 |
| Total non-operating income (expense) | 2,737 | 9,930 | 6,999 | 2,223 | -5,803 | -11,546 |
| Income before income taxes | -33,376 | -63,118 | · | · | · | · |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income including non-controlling interests | -33,376 | -63,118 | -69,197 | -88,098 | -98,591 | -60,728 |
| Net income | -33,376 | -63,118 | -69,197 | -88,098 | -98,591 | -60,728 |
| Earnings per share, basic | -17.85 | -33.06r | -36.60b | -47.20b | -59.40b | · |
| Earnings per share, diluted | -17.85 | -33.06r | -36.60b | -47.20b | -59.40b | · |
| Earnings per share, basic and diluted | · | · | · | · | -59.40b | -577.80b |
| Weighted average shares, basic | 1,869,924 | 1,909,225r | 1,890,599b | 1,867,921b | 1,659,836rb | 1,989,208 |
| Weighted average shares, diluted | 1,869,924 | 1,909,225r | 1,890,599b | 1,867,921b | 1,659,836b | · |
| Weighted average shares, basic and diluted | · | · | · | · | 1,659,836b | 105,116b |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-20 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeNetTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted